Suche Bilder Maps Play YouTube News Gmail Drive Mehr »
Einstellungen | Anmelden

AML Analyst

Amlin (LON:AML) Analyst Target Changes

Fiscal Standard - ‎17.07.2016‎
A number of investment brokers have recently updated their price targets on shares of Amlin (LON:AML). According to the latest broker reports outstanding on Monday 18th of July, n/a analysts have a rating of “strong buy”, n/a analysts “buy”, n/a ...

GNW-News: Merus gibt Finanzergebnisse des ersten Quartals 2016 bekannt ...

OnVista (Pressemitteilung) - ‎15.07.2016‎
Bekanntgabe, dass der erste Patient die Dosis in einer klinischen Phase- I/II-Prüfung erhalten hat, bei der der zweite Biclonics®-Therapeutikum- Kandidat von Merus, MCLA-117, bei Patienten mit akuter myeloischer Leukämie (AML) untersucht wird ...

Commission creating more risk of money laundering, not less

EurActiv - ‎vor 22 Stunden‎
Tom Keatinge is an analyst of terrorist and extremist financing and is director of the Centre for Financial Crime & Security Studies.

Celgene (CELG) Mark J. Alles on Q2 2016 Results - Earnings Call Transcript

Seeking Alpha - ‎vor 15 Stunden‎
Good morning, and welcome to the Celgene second quarter 2016 earnings conference call. I would like to remind you this call is being recorded.
Echtzeit-Berichte

Barclays Capital reiterated Seattle Genetics (NASDAQ:SGEN) as 'Overweight ...

FTSE News - ‎vor 15 Stunden‎
The analyst stated that the investment firm has set a price target of 53 on shares of NASDAQ:SGEN. Based on the brokers price target of 53, this means Barclays Capital believes there is a potential increase of 13.49% from the current stock price of 46.7.
Echtzeit-Berichte

Singapore Puts 1MDB-Linked Banks on Notice: We're Not Done

Bloomberg - ‎21.07.2016‎
In a statement Thursday, the Monetary Authority of Singapore rebuked UBS, DBS Group Holdings Ltd. and two other banks for weaknesses in anti-money laundering controls related to transactions tied to 1Malaysia Development Bhd. MAS is still examining ...

JP Morgan Pounds the Table on Celgene Corporation (CELG)

Smarter Analyst - ‎20.07.2016‎
J.P. Morgan analyst Cory Kasimov is upbeat about the prospects of biopharmaceutical giant Celgene Corporation (NASDAQ:CELG), discussing optimistic outlook guidance for the upcoming years into 2020, as part of his Summer Spotlight Series.

North Korea says it may review cooperation with FATF

NK News - ‎18.07.2016‎
North Korea's National Coordination Committee for AML/CFT (anti-money laundering and countering the financing of terrorism) sent a letter to the Financial Action Task Force (FATF) implying it may review its cooperation with the organisation, an article ...

Global Anti-Money Laundering Software Market to Rise at CAGR 11% During ...

Digital Journal - ‎27.07.2016‎
Technavios market research analyst predicts the global anti-money laundering (AML) software market to grow steadily at a CAGR of around 11% during the forecast period.

Bilawal rides high at early age

The Nation - ‎24.07.2016‎
At a recent media interaction here, the PPP chief won admiration from the journalists and the analysts who had expected him to take time to gain political maturity.
Echtzeit-Berichte

Syros Pharmaceuticals (NASDAQ:SYRS) Receives Outperform Rating From ...

Fiscal Standard - ‎25.07.2016‎
Syros Pharmaceuticals (NASDAQ:SYRS) had its stock rating indicated as 'Outperform' in a report released by analysts at Wedbush. ... SY-1425 is approved as tamibarotene in Japan for the treatment of acute promyelocytic leukemia (APL), a form of AML.

New report: Global anti-money laundering software market growing steadily at ...

WhaTech - ‎26.07.2016‎
Technavios market research analyst predicts the global anti-money laundering (AML) software market to grow steadily at a CAGR of around 11% during the forecast period.

Kris Finsoftware and CustomerXPs Launch Clari5, Voted Best Fraud Detection ...

IT News Online - ‎28.07.2016‎
Bangalore, India, July 28, 2016 --(PR.com)-- Kris Finsoftware and CustomerXPs have been collaborating extensively on product customization for Asia Pacific's key countries and have incorporated significant changes in the customized product based on ...

Kris Finsoftware & CustomerXPs Launch Clari5,Extreme Real-time Fraud ...

EIN News (press release) - ‎26.07.2016‎
MAS announced a new anti-money-laundering department after it ordered the local arm of a Swiss bank to shut down operations in relation to a laundering and bribery probe.

Hematological Cancers - Highly Innovative Pipeline Continues Trend Towards ...

Digital Journal - ‎25.07.2016‎
Market Research Reports, Inc. has announced the addition of “Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies” research report to their website www.

Sunesis Pharmaceuticals Incorporated New (NASDAQ:SNSS) Shorted Shares ...

Press Telegraph - ‎22.07.2016‎
The Firm offers QINPREZO , which is a product candidate for the treatment of acute myeloid leukemia (AML). Out of 3 analysts covering Sunesis Pharmaceuticals (NASDAQ:SNSS), 0 rate it a “Buy”, 1 “Sell”, while 2 “Hold”. This means 0 are positive. Sunesis ...

Champions Oncology Successfully Delivers First AML Study

SYS-CON Media (press release) - ‎18.07.2016‎
Champions Oncology identified AML as an area of significant unmet customer need and has been pursuing two technological approaches for developing AML models in conjunction with external collaborators. The first approach involves AML modeling from ...

Investors Watch List: GlycoMimetics, Inc. (NASDAQ:GLYC), AstroNova, Inc ...

Benchmark Monitor - ‎18.07.2016‎
On 28 June, GlycoMimetics, Inc. (NASDAQ:GLYC) announced closing of the first patient with newly diagnosed acute myeloid leukemia (AML) in the Phase 2 portion of its ongoing Phase 1/2 study evaluating its novel E-selectin antagonist, GMI-1271, combined ...

GlycoMimetics Inc (GLYC) Current Analyst Ratings

Fiscal Standard - ‎20.07.2016‎
The Company is developing GMI-1271, a specific E-selectin inhibitor, to be used in combination with chemotherapy to treat patients with acute myeloid leukemia (AML), multiple myeloma (MM) and other hematologic cancers. The Company has an additional ...

Verafin Announces New Full-Day Conferences Covering Emerging Trends in ...

SYS-CON Media (press release) - ‎20.07.2016‎
Following the success of the FRAMLx Tour in early 2016 and last year's FRAMLxpo, Verafin Inc., a leading provider of fraud detection and anti-money laundering collaboration (FRAMLx) software, this week announced four new full-day educational ...
 -